Profile data is unavailable for this security.
About the company
EMS-CHEMIE HOLDING AG is a Switzerland-based holding company and producer and supplier of polymers and chemicals. The Company operates in two business segments: High Performance Polymers and Specialty Chemicals. The High Performance Polymers business segment comprises EMS-GRIVORY, a manufacturer of high-performance polyamides and the supplier of a range of polyamide materials, and EMS-EFTEC, a supplier of adhesives, sealants and coatings including application engineering systems for the automotive industry worldwide. The Specialty Chemicals business segment includes EMS-PATVAG, which specializes in igniters for airbag gas generators, and EMS-GRILTECH, which manufactures and sells Grilon, Nexylon and Nexylene fibers, Griltex hotmelt adhesives, Grilbond adhesion promoters, Primid crosslinkers for powder-coatings and Grilonit reactive diluents. The Company operates through its subsidiaries in Europe, Asia, North and South America, and has 26 production sites in 16 different countries.
- Revenue in CHF (TTM)2.09bn
- Net income in CHF461.97m
- Incorporated1962
- Employees2.77k
- LocationEms Chemie Holding AGFuederholzstrasse 34HERRLIBERG 8704SwitzerlandCHE
- Phone+41 449157000
- Fax+41 449157002
- Websitehttps://www.ems-group.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Evonik Industries AG | 14.12bn | 212.32m | 7.64bn | 33.58k | 36.63 | 0.9092 | 6.33 | 0.5407 | 0.4803 | 0.4803 | 32.02 | 19.35 | 0.7514 | 4.22 | 8.64 | 453,859.80 | 1.21 | 2.01 | 1.54 | 2.42 | 25.25 | 25.47 | 1.61 | 2.90 | 0.7371 | 9.95 | 0.3168 | 130.72 | -17.42 | 2.85 | -186.27 | -- | -3.51 | 0.3454 |
Imcd NV | 4.23bn | 261.52m | 7.71bn | 5.01k | 28.41 | 4.56 | 20.30 | 1.82 | 4.93 | 4.93 | 79.74 | 30.72 | 1.08 | 5.53 | 5.22 | 958,630.50 | 6.66 | 7.01 | 9.66 | 9.60 | 22.37 | 21.40 | 6.19 | 5.80 | 0.8846 | 5.67 | 0.5087 | 44.25 | -3.45 | 13.30 | -6.65 | 23.91 | 24.09 | 22.87 |
Brenntag SE | 15.08bn | 507.04m | 8.15bn | 17.70k | 16.50 | 2.00 | 9.89 | 0.5408 | 3.67 | 3.67 | 109.07 | 30.28 | 1.49 | 8.20 | 6.72 | 914,269.60 | 5.10 | 6.40 | 7.30 | 9.02 | 24.66 | 23.03 | 3.41 | 4.02 | 1.04 | 10.12 | 0.4348 | 37.40 | -13.45 | 6.03 | -19.38 | 9.18 | 12.47 | 11.84 |
Akzo Nobel NV | 9.89bn | 526.13m | 8.89bn | 35.40k | 16.90 | 2.09 | 9.77 | 0.8985 | 3.31 | 3.29 | 61.96 | 26.80 | 0.6991 | 3.57 | 3.75 | 301,733.00 | 4.00 | 4.15 | 6.59 | 6.06 | 40.82 | 40.51 | 5.72 | 6.07 | 0.8947 | 4.71 | 0.5651 | 63.75 | -1.64 | 2.88 | 23.48 | 2.25 | 12.32 | 1.41 |
Symrise AG | 4.55bn | 365.40m | 13.80bn | 12.54k | 37.78 | 3.94 | 21.00 | 3.03 | 2.81 | 2.81 | 34.92 | 26.90 | 0.6186 | 2.40 | 4.94 | 392,584.40 | 5.02 | 4.99 | 5.80 | 5.95 | 37.10 | 37.93 | 8.11 | 8.13 | 1.64 | 7.17 | 0.401 | 43.83 | 2.42 | 8.44 | 21.59 | 4.04 | 3.44 | 4.10 |
Ems Chemie Holding AG | 2.09bn | 461.97m | 14.96bn | 2.77k | 32.38 | 7.48 | 28.91 | 7.15 | 19.75 | 19.75 | 89.46 | 85.44 | 0.8586 | -- | 6.07 | 764,838.10 | 19.13 | 22.72 | 22.11 | 27.29 | -- | 45.02 | 22.28 | 23.25 | 3.72 | 245.25 | 0.0153 | 87.87 | -10.36 | -1.14 | -14.01 | -2.51 | -3.87 | 1.57 |
Novozymes A/S | 2.84bn | 263.61m | 22.03bn | 10.45k | 61.47 | 2.41 | 37.38 | 7.77 | 6.92 | 6.92 | 67.31 | 176.56 | 0.32 | 2.66 | 5.05 | 3,551,292.00 | 2.96 | 13.46 | 3.43 | 17.84 | 46.67 | 55.56 | 9.25 | 20.12 | 0.687 | 12.09 | 0.1531 | 38.89 | 1.82 | 4.47 | -17.86 | -1.28 | 8.12 | 4.41 |
Holder | Shares | % Held |
---|---|---|
UBS Asset Management Switzerland AGas of 05 Nov 2024 | 390.16k | 1.67% |
The Vanguard Group, Inc.as of 06 Nov 2024 | 244.91k | 1.05% |
Norges Bank Investment Managementas of 30 Jun 2024 | 149.31k | 0.64% |
BlackRock Fund Advisorsas of 07 Nov 2024 | 146.69k | 0.63% |
BlackRock Asset Management Deutschland AGas of 08 Nov 2024 | 91.11k | 0.39% |
Z�rcher Kantonalbank (Investment Management)as of 30 Aug 2024 | 87.06k | 0.37% |
Pictet Asset Management SAas of 30 Jun 2024 | 85.11k | 0.36% |
Geode Capital Management LLCas of 21 Nov 2024 | 70.12k | 0.30% |
BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 63.26k | 0.27% |
VV Verm�gensverwaltung AGas of 30 Aug 2024 | 61.80k | 0.26% |